Showing results (41-50 of 55) with videos related to
Sort By:
Pageof 6
European Journal of Cancer Care|October 20, 2007
Men with cancer: is their use of complementary and alternative medicine a response to needs unmet by conventional care?M A Evans, A R G Shaw, D J Sharp, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|December 12, 2001
A new device for the measurement of disease severity in patients with intermittent claudicationP A Coughlin, P J Kent, E P Turton, et al.Circulation|October 1, 1984
Validation of quantitation of regional myocardial blood flow in vivo with 11C-labeled human albumin microspheres and positron emission tomographyR A Wilson, M J Shea, C M De Landsheere, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|October 27, 1998
Exercise-induced neutrophil activation in claudicants: a physiological or pathological response to exhaustive exercise?E P Turton, J I Spark, K G Mercer, et al.BMJ (Clinical Research Ed.)|April 14, 2000
Randomised controlled trial of nurse practitioner versus general practitioner care for patients requesting "same day" consultations in primary careP Kinnersley, E Anderson, K Parry, et al.European Journal of Vascular and Endovascular Surgery : the Official Journal of the European Society for Vascular Surgery|March 27, 1999
Duplex-derived evidence of reflux after varicose vein surgery: neoreflux or neovascularisation?E P Turton, D J Scott, S P Richards, et al.Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|July 1, 1991
Measurement of cerebral monoamine oxidase B activity using L-[11C]deprenyl and dynamic positron emission tomographyA A Lammertsma, C J Bench, G W Price, et al.European Journal of Clinical Pharmacology|January 1, 1991
Measurement of human cerebral monoamine oxidase type B (MAO-B) activity with positron emission tomography (PET): a dose ranging study with the reversible inhibitor Ro 19-6327C J Bench, G W Price, A A Lammertsma, et al.The Journal of Clinical Endocrinology and Metabolism|December 7, 2006
HESX1 mutations are an uncommon cause of septooptic dysplasia and hypopituitarismDavid E G McNay, James P Turton, Daniel Kelberman, et al.Nature|January 4, 1996
A role for glucagon-like peptide-1 in the central regulation of feedingM D Turton, D O'Shea, I Gunn, et al.Pageof 6